-
Something wrong with this record ?
How to advance from minimally invasive coronary artery bypass grafting to totally endoscopic coronary bypass grafting: challenges in Europe versus United States of America
M. Algoet, T. Melvin, S. Cerny, J. Bonatti, S. Singh, T. Folliguet, P. Modi, U. Franke, M. Gianoli, A. Agnino, F. Casselman, W. Oosterlinck
Status not-indexed Language English Country China
Document type Journal Article, Review
NLK
Free Medical Journals
from 2012
Freely Accessible Journals
from 2012
PubMed Central
from 2012
Europe PubMed Central
from 2012
- Publication type
- Journal Article MeSH
- Review MeSH
Robotic coronary and intra-cardiac surgery has been available for more than 25 years. In this period, multiple studies have demonstrated the beneficial effects of robotic surgery over conventional open surgery. Throughout the years, technical developments have enabled us to perform totally endoscopic coronary artery bypass (TECAB) grafting. But these techniques remained in the hands of a small group of pioneers because of a lack of structured training programs and the absence of long-term results at that time. Currently, a renewed interest and a wide dispersion of robotic platforms, thanks to use of robotics in other disciplines, has led to an exponential increase in robotic cardiac centers both in Europe and USA. Nonetheless, this increase was slowed down in Europe as a result of the uncertainty introduced by the implementation of a revised regulatory framework for medical devices [Regulation 2017/745, 'Medical Device Regulation' ('MDR')]. The MDR was introduced with the goal of increasing patient safety and supporting innovation. Implementing the MDR has proven to be exceptionally challenging and risks to the supply of essential devices have been identified. Changes to both regulatory and market dynamics led to a circumstance where the only available robotic platform for cardiac surgery decided to cease marketing of essential accessories for conducting surgery. This resulted in the disappearance of dedicated tools such as the Endowrist stabilizer, essential for TECAB, and the atrial retractor which is essential for intra-cardiac surgery. In the mean-time, further clinical evidence was published demonstrating the superiority of robotic cardiac surgery over other minimally invasive approaches. This has demonstrated the need to better define the clinical evidence requirements for regulatory purposes to ensure that dedicated tools for evidence-based interventions in robotic coronary surgery remain available such that TECAB can continue in Europe.
Cardiothoracic Surgery Department Na Homolce Hospital Prague Czech Republic
Cardiovascular Center Aalst OLV Clinic Aalst Aalst Belgium
Department of Cardiac Surgery Humanitas Gavazzeni Bergamo Italy
Department of Cardiac Surgery University Medical Centre Utrecht Utrecht The Netherlands
Department of Cardiovascular Sciences Research Unit of Cardiac Surgery KU Leuven Leuven Belgium
Department of Cardiovascular Surgery Robert Bosch Hospital Stuttgart Germany
ISALA Hospital Zwolle The Netherlands
School of Medicine Trinity College Dublin Dublin Ireland
The Liverpool Heart and Chest Hospital NHS Foundation Trust Liverpool UK
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25002454
- 003
- CZ-PrNML
- 005
- 20250123101914.0
- 007
- ta
- 008
- 250117s2024 cc f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.21037/acs-2023-rcabg-0210 $2 doi
- 035 __
- $a (PubMed)39434975
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a cc
- 100 1_
- $a Algoet, Michiel $u Department of Cardiovascular Sciences, Research Unit of Cardiac Surgery, KU Leuven, Leuven, Belgium
- 245 10
- $a How to advance from minimally invasive coronary artery bypass grafting to totally endoscopic coronary bypass grafting: challenges in Europe versus United States of America / $c M. Algoet, T. Melvin, S. Cerny, J. Bonatti, S. Singh, T. Folliguet, P. Modi, U. Franke, M. Gianoli, A. Agnino, F. Casselman, W. Oosterlinck
- 520 9_
- $a Robotic coronary and intra-cardiac surgery has been available for more than 25 years. In this period, multiple studies have demonstrated the beneficial effects of robotic surgery over conventional open surgery. Throughout the years, technical developments have enabled us to perform totally endoscopic coronary artery bypass (TECAB) grafting. But these techniques remained in the hands of a small group of pioneers because of a lack of structured training programs and the absence of long-term results at that time. Currently, a renewed interest and a wide dispersion of robotic platforms, thanks to use of robotics in other disciplines, has led to an exponential increase in robotic cardiac centers both in Europe and USA. Nonetheless, this increase was slowed down in Europe as a result of the uncertainty introduced by the implementation of a revised regulatory framework for medical devices [Regulation 2017/745, 'Medical Device Regulation' ('MDR')]. The MDR was introduced with the goal of increasing patient safety and supporting innovation. Implementing the MDR has proven to be exceptionally challenging and risks to the supply of essential devices have been identified. Changes to both regulatory and market dynamics led to a circumstance where the only available robotic platform for cardiac surgery decided to cease marketing of essential accessories for conducting surgery. This resulted in the disappearance of dedicated tools such as the Endowrist stabilizer, essential for TECAB, and the atrial retractor which is essential for intra-cardiac surgery. In the mean-time, further clinical evidence was published demonstrating the superiority of robotic cardiac surgery over other minimally invasive approaches. This has demonstrated the need to better define the clinical evidence requirements for regulatory purposes to ensure that dedicated tools for evidence-based interventions in robotic coronary surgery remain available such that TECAB can continue in Europe.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Melvin, Tom $u School of Medicine, Trinity College Dublin, Dublin, Ireland
- 700 1_
- $a Cerny, Stepan $u Cardiothoracic Surgery Department, Na Homolce Hospital, Prague, Czech Republic
- 700 1_
- $a Bonatti, Johannes $u Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
- 700 1_
- $a Singh, Sandeep $u ISALA Hospital, Zwolle, The Netherlands
- 700 1_
- $a Folliguet, Thierry $u Department of Cardio-Thoracic Surgery, University Hospital Henri-Mondor, Assistance Publique-Hopitaux de Paris Créteil, Paris, France
- 700 1_
- $a Modi, Paul $u The Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, UK
- 700 1_
- $a Franke, Ulrich $u Department of Cardiovascular Surgery, Robert Bosch Hospital, Stuttgart, Germany
- 700 1_
- $a Gianoli, Monica $u Department of Cardiac Surgery, University Medical Centre Utrecht, Utrecht, The Netherlands
- 700 1_
- $a Agnino, Alfonso $u Department of Cardiac Surgery, Humanitas Gavazzeni, Bergamo, Italy
- 700 1_
- $a Casselman, Filip $u Cardiovascular Center Aalst, OLV Clinic Aalst, Aalst, Belgium
- 700 1_
- $a Oosterlinck, Wouter $u Department of Cardiovascular Sciences, Research Unit of Cardiac Surgery, KU Leuven, Leuven, Belgium
- 773 0_
- $w MED00201247 $t Annals of cardiothoracic surgery $x 2225-319X $g Roč. 13, č. 5 (2024), s. 397-408
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39434975 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250117 $b ABA008
- 991 __
- $a 20250123101908 $b ABA008
- 999 __
- $a ok $b bmc $g 2254584 $s 1238457
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2024 $b 13 $c 5 $d 397-408 $e 20240923 $i 2225-319X $m Annals of cardiothoracic surgery $n Ann Cardiothorac Surg $x MED00201247
- LZP __
- $a Pubmed-20250117